rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2005-3-22
|
pubmed:abstractText |
8-hydroxydeoxyguanosine (8-OHdG) has been used to evaluate oxidative stress. The authors investigated urinary 8-OHdG levels in 72 patients with Parkinson disease (PD) and in normal and disease control groups. The mean urinary 8-OHdG increased with the stage of PD and was not influenced by the current dose of DOPA. Our results suggest that urinary 8-OHdG is a potentially useful biomarker for evaluating the progression of PD.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1526-632X
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
22
|
pubmed:volume |
64
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1081-3
|
pubmed:meshHeading |
pubmed-meshheading:15781836-Adult,
pubmed-meshheading:15781836-Aged,
pubmed-meshheading:15781836-Aged, 80 and over,
pubmed-meshheading:15781836-Biological Markers,
pubmed-meshheading:15781836-Brain,
pubmed-meshheading:15781836-Creatinine,
pubmed-meshheading:15781836-Deoxyguanosine,
pubmed-meshheading:15781836-Dihydroxyphenylalanine,
pubmed-meshheading:15781836-Disease Progression,
pubmed-meshheading:15781836-Dopamine Agents,
pubmed-meshheading:15781836-Dose-Response Relationship, Drug,
pubmed-meshheading:15781836-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:15781836-Female,
pubmed-meshheading:15781836-Humans,
pubmed-meshheading:15781836-Male,
pubmed-meshheading:15781836-Middle Aged,
pubmed-meshheading:15781836-Oxidative Stress,
pubmed-meshheading:15781836-Parkinson Disease,
pubmed-meshheading:15781836-Predictive Value of Tests
|
pubmed:year |
2005
|
pubmed:articleTitle |
Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease.
|
pubmed:affiliation |
Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
|
pubmed:publicationType |
Journal Article
|